GENERAL COMMENTARY article
Commentary: A Systematic Evaluation of Single Cell RNA-Seq Analysis Pipelines
- 1Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan
- 2Collaborative Research Institute for Innovative Microbiology, The University of Tokyo, Tokyo, Japan
- 3Interfaculty Initiative in Information Studies, The University of Tokyo, Tokyo, Japan
by Vieth, B., Parekh, S., Ziegenhain, C., Enard, W., and Hellmann, I. (2019). Nat. Commun. 10:4667. doi: 10.1038/s41467-019-12266-7
RNA sequencing (RNA-seq) is a common tool for obtaining data related to gene expression (Mortazavi et al., 2008). Identification of genes exhibiting differential expression (DE) in different groups or conditions is critical to analysis of RNA-seq data (Osabe et al., 2019). Recently, Vieth et al. (2019) evaluated a total of 3,000 possible single-cell RNA-seq (scRNA-seq) analysis pipelines, encompassing the entire analytical process—from library preparation protocols to identification of DE genes. By performing a simulated analysis to compare two-group data under various conditions, they found that method of normalization and choice of library preparation protocol had the greatest impact on the outcome of scRNA-seq analyses. Though we agree with the main conclusion, the stated motivation for the research is insufficient and misleading to readers. In short, Vieth et al. neglect the contributions of previous studies based on bulk RNA-seq. In this commentary, we provide facts about what they claim as the differences between scRNA-seq and bulk RNA-seq when performing DE analysis.
There are two main criticisms. First, Vieth et al. state, “One main assumption in traditional DE-analysis is that differences in expression are symmetric.” They subsequently state, “This implies that either a small fraction of genes is DE while the expression of the majority of genes remains constant or similar numbers of genes are up- and down-regulated so that the mean total mRNA content does differ between groups.” Finally, they state, “This assumption is no longer true when diverse cell types are considered.” The second half of the second sentence is probably wrong. Unless they write “the mean total mRNA content does NOT differ between groups,” the relationship with the surrounding text is not logical. Importantly, the asymmetry is already addressed by some previous studies with bulk RNA-seq (Kadota et al., 2012; Evans et al., 2018). Second, as an example, Vieth et al. mentioned an scRNA-seq study that found up to 60% DE genes and differing amounts of total mRNA levels between cell types (Zeisel et al., 2015) for distinguishing scRNA-seq from bulk RNA-seq. However, even the tendency to obtain a large number of DE genes between cell types cannot distinguish these. For example, a bulk RNA-seq dataset exists (Schurch et al., 2016) that can produce nearly 70% DE genes (Zhao et al., 2018). A common feature of these data sets is a high number of replicates (>40 replicates per group). A typical number of cells per cell type in scRNA-seq corresponds to a very large number of replicates per group in bulk RNA-seq. Therefore, a necessary condition for obtaining many DE genes would be the number of replicates.
Regarding the first criticism, we previously showed the need for asymmetry and developed a robust normalization method (dubbed TbT) for manipulation in both symmetric and asymmetric scenarios (Kadota et al., 2012). Although TCC, the R package (Sun et al., 2013) that implements both TbT and DEGES (the generalized form of TbT), evaluated a limited extent of scenarios (~25% DE), Evans et al. (2018) covered the shortfall in an analysis of approximately 5–95% DE when both symmetric and asymmetric scenarios were evaluated. Although Evans et al. (2018) did not perform many replicates in their simulation settings (~five replicates in Figures 7, 8), they still provide important suggestions for asymmetry conditions. Notably, DEGES outperforms the other methods at ~60% DE conditions; this is included in the simulation scenarios of Vieth et al. (2019). Despite citing the paper of Evans et al., Vieth et al. (2019) added only the representative bulk methods, TMM (Robinson and Oshlack, 2010) and MR (Anders and Huber, 2010), in their comparison and recommended the use of scran (Lun et al., 2016), which has been developed specifically for scRNA-seq. This is misleading to the reader because representative methods are not always accurate. Researchers should thoroughly investigate the most accurate method for given simulation conditions for inclusion in comparative analyses, and make conclusions/recommendations based on the outcomes. We expect the recommendations from Vieth et al. would be different if they had honestly compared the best bulk method (i.e., DEGES) as well as the representative bulk methods (i.e., TMM and MR).
Related to the second criticism, Vieth et al. (2019) found that relatively straightforward DE-testing methods adapted from bulk RNA-seq perform well with scRNA-seq data and reasoned that scRNA-seq data obtained from unique molecular identifier (UMI) counting are well fit to a negative binomial (NB) distribution (Vieth et al., 2017, 2019). Along with other recent reports (e.g., Van den Berge et al., 2018), it is becoming more apparent that there is no need to distinguish between scRNA-seq and bulk RNA-seq data, at least in DE analysis. Still, some researchers may believe that the high frequency of zero values (i.e., zero-inflation) in scRNA-seq data obtained from tools like Smart-seq2 (Picelli et al., 2014) is a main characteristic that distinguishes bulk RNA-seq data. Nevertheless, many researchers are probably not aware that characteristic zero-inflation has already been found in bulk RNA-seq data with large number of replicates (Esnaola et al., 2013). To the best of our knowledge, the report by Esnaola et al. is the first one describing the need to consider zero-inflation; the authors employed the Poisson-Tweedie family of distributions to consider both zero-inflation and heavy tail behavior. In our opinion, the contributions of Esnaola et al. should be cited when discussing zero-inflation (e.g., Tang et al., 2015).
Taken together, there is no special reason to distinguish between scRNA-seq and bulk RNA-seq, especially in DE analysis. Despite the advances in experimental technology from bulk RNA-seq to scRNA-seq, universally applicable algorithms do exist.
KK drafted the manuscript. KS supervised the critical discussion and refined the paper. All authors read and approved the final manuscript.
This work was supported by JSPS KAKENHI Grant Number JP18K11521.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
We would like to thank Editage (www.editage.jp) for english language editing.
Esnaola, M., Puig, P., Gonzalez, D., Castelo, R., and Gonzalez, J. R. (2013). A flexible count data model to fit the wide diversity of expression profiles arising from extensively replicated RNA-seq experiments. BMC Bioinformatics 14:254. doi: 10.1186/1471-2105-14-254
Evans, C., Hardin, J., and Stoebel, D. M. (2018). Selecting between-sample RNA-Seq normalization methods from the perspective of their assumptions. Brief. Bioinform. 19, 776–792. doi: 10.1093/bib/bbx008
Osabe, T., Shimizu, K., and Kadota, K. (2019). Accurate Classification of differential expression patterns in a bayesian framework with robust normalization for multi-group RNA-Seq count data. Bioinform. Biol. Insights 13:1177932219860817. doi: 10.1177/1177932219860817
Picelli, S., Faridani, O. R., Björklund, A. K., Winberg, G., Sagasser, S., and Sandberg, R. (2014). Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 9, 171–181. doi: 10.1038/nprot.2014.006
Schurch, N. J., Schofield, P., Gierliński, M., Cole, C., Sherstnev, A., Singh, V., et al. (2016). How many biological replicates are needed in an RNA-seq experiment and which differential expression tool should you use? RNA 22, 839–851. doi: 10.1261/rna.053959.115
Sun, J., Nishiyama, T., Shimizu, K., and Kadota, K. (2013). TCC: an R package for comparing tag count data with robust normalization strategies. BMC Bioinformatics 14:219. doi: 10.1186/1471-2105-14-219
Tang, M., Sun, J., Shimizu, K., and Kadota, K. (2015). Evaluation of methods for differential expression analysis on multi-group RNA-seq count data. BMC Bioinformatics 16:361. doi: 10.1186/s12859-015-0794-7
Van den Berge, K., Perraudeau, F., Soneson, C., Love, M. I., Risso, D., Vert, J. P., et al. (2018). Observation weights unlock bulk RNA-seq tools for zero inflation and single-cell applications. Genome Biol. 19:24. doi: 10.1186/s13059-018-1406-4
Vieth, B., Ziegenhain, C., Parekh, S., Enard, W., and Hellmann, I. (2017). powsimR: power analysis for bulk and single cell RNA-seq experiments. Bioinformatics 33, 3486–3488. doi: 10.1093/bioinformatics/btx435
Zeisel, A., Muñoz-Manchado, A. B., Codeluppi, S., Lönnerberg, P., La Manno, G., Juréus, A., et al. (2015). Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science 347, 1138–1142. doi: 10.1126/science.aaa1934
Keywords: differential expression analysis, normalization, bulk RNA-seq, scRNA-seq, asymmetry/asymmetric, transcriptome, gene expression
Citation: Kadota K and Shimizu K (2020) Commentary: A Systematic Evaluation of Single Cell RNA-Seq Analysis Pipelines. Front. Genet. 11:941. doi: 10.3389/fgene.2020.00941
Received: 04 March 2020; Accepted: 28 July 2020;
Published: 04 September 2020.
Edited by:Dapeng Wang, University of Leeds, United Kingdom
Reviewed by:Hauke Busch, University of Lübeck, Germany
Copyright © 2020 Kadota and Shimizu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Koji Kadota, email@example.com